Company / Capital Expenditures
TransMedics Group, Inc. Capital Expenditures History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$59.3M
FY2025
5-year range
$3.5M / $151.8M
FY2021-FY2025
Trend
-54.3%
vs FY2024
Sector context
#74 of 145
Health Care
What the data says
At $59M, TransMedics Group, Inc.'s capital expenditures ranks #74 of 145 in the Health Care sector. Declined from $152M to $59M over the past 2 years.
Based on SEC 10-K filings.
$59M in FY2025 with a 5-year CAGR of +164.8%.
Declined from $152M to $59M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +70.7%
- 5-Year CAGR
- +164.8%
- 10-Year CAGR
- -
Sector benchmark
#74 of 145 in Health CareTop 51% of 145This company $59.3M Sector average $268.6M
▼
-77.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +164.8%, indicating consistent growth.
- In FY2025, capital expenditures decreased 54.3% year-over-year.
- Ranks #74 out of 145 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2023.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $59.3M | -54.3% |
| FY2024 | $129.7M | -14.6% |
| FY2023 | $151.8M | +1175.3% |
| FY2022 | $11.9M | +238.4% |
| FY2021 | $3.5M | +673.4% |
| FY2020 | $455.0K | +175.8% |
| FY2019 | $165.0K | -60.5% |
| FY2018 | $418.0K | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026